Jazz Pharmaceuticals
JAZZ
JAZZ
417 hedge funds and large institutions have $6.52B invested in Jazz Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 155 increasing their positions, 128 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
417
Holders Change
+15
Holders Change %
+3.73%
% of All Funds
9.31%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.11%
New
83
Increased
155
Reduced
128
Closed
65
Calls
$18M
Puts
$26.1M
Net Calls
-$8.03M
Net Calls Change
+$30.5M
Top Buyers
| 1 |
LSV Asset Management
Chicago,
Illinois
|
+$57.8M |
| 2 |
SI
Scout Investments
Kansas City,
Missouri
|
+$54.7M |
| 3 |
CGM
Capital Growth Management
Boston,
Massachusetts
|
+$40.9M |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$37.6M |
| 5 |
Renaissance Technologies
New York
|
+$31.5M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$161M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$154M |
| 3 |
O
OrbiMed
New York
|
-$149M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$143M |
| 5 |
AII
AGF Investments Inc
Toronto,
Ontario, Canada
|
-$77.1M |
